The Vanguard Group Discloses Position in Mural Oncology plc

The Vanguard Group, Inc. has submitted a disclosure form under Rule 8.3 of the Irish Takeover Panel Act. This disclosure concerns Mural Oncology plc. The form reveals that Vanguard holds 4.47% interest in Mural Oncology with 772,371 ordinary shares.

The form, dated 11 August 2025, indicates no involvement in any cash-settled or stock-settled derivatives in relation to the interest. The document also confirms that there were no agreements or arrangements concerning voting rights related to these securities.

No supplemental Form 8 was attached, signaling no additional disclosures were deemed necessary. This release forms part of regulatory requirements to inform stakeholders of significant shareholding positions in the context of a takeover or merger.